Clinical Trial Update: Psilocybin for Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 study evaluating psilocybin for Major Depressive Disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Major Depressive Disorder | Phase 2 | Status: WITHDRAWN